Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
A. M. Shete, P. D. Yadav, A. Kumar, S. Patil, D. Y. Patil, Y. Joshi, T. Majumdar, V. Relhan, R. R. Sahay, M. Vasu, P. Gawande, A. Verma, A. Kumar, S. Dhakad, A. B. Krishnan, , P. Abraham
The paper analyzes Monkeypox virus genomes from India, identifying three subclusters within the A.2 lineage and additional APOBEC3 mutations.
bioRxiv · Sep 16, 2022Microbiology
A. M. Shete, D. Y. Patil, R. R. Sahay, G. N. Sapkal, G. R. Deshpande, P. Yadav
The paper examines six cases of SARS-CoV-2 reinfection following primary infection and Covishield vaccination, showing reduced hybrid immunity and the need for booster doses.
bioRxiv · May 12, 2022 · PreprintMicrobiology
P. D. Yadav, G. Sapkal, R. R. Sahay, V. Potdar, G. Deshpande, D. Y. Patil, D. A. Nyayanit, A. M. Shete, J. Shastri, P. Awate, B. Malhotra, P. Abraham
This study compares IgG and neutralizing antibody responses in vaccinated and unvaccinated individuals infected with the Omicron variant of SARS-CoV-2, showing reduced neutralization against Omicron compared to earlier variants.
bioRxiv · Jan 24, 2022Microbiology
S. Mohandas, P. D. Yadav, G. Sapkal, A. M. Shete, G. Deshpande, D. A. Nyayanit, D. Y. Patil, M. Kadam, A. Kumar, C. Mote, R. Jain
This study evaluates the pathogenicity of SARS-CoV-2 Omicron BA.1 in Syrian hamsters and finds reduced cross-neutralization against other variants.
bioRxiv · Jan 19, 2022 · PreprintMicrobiology
P. D. Yadav, N. Gupta, V. Potdar, S. Mohandas, R. R. Sahay, P. Sarkale, A. M. Shete, A. Razdan, D. Y. Patil, D. A. Nyayanit, Y. Joshi, S. Patil, T. Majumdar, H. Dighe, B. Malhotra, , P. Abraham
The paper isolates the Omicron variant from Syrian hamsters and compares its genetic changes to human clinical specimens and Vero CCL-81 cell passages.
bioRxiv · Jan 2, 2022 · PreprintMicrobiology
P. D. Yadav, G. Sapkal, R. Ella, R. R. Sahay, D. A. Nyayanit, D. Y. Patil, G. Deshpande, A. M. Shete, N. Gupta, V. K. Mohan, P. Abraham, S. Panda, B. Bhargava
This study assesses the neutralization efficacy of sera from COVID-19 recovered cases and BBV152 vaccinees against SARS-CoV-2 variants B.1.351 and B.1.617.2, showing reduced titers but still protective responses.
bioRxiv · Jun 5, 2021 · PreprintMicrobiology
P. D. Yadav, S. Mohandas, A. M. Shete, D. A. Nyayanit, N. Gupta, D. Y. Patil, G. N. Sapkal, V. Potdar, M. Kadam, A. kumar, S. Kumar, D. Suryavanshi, C. S. Mote, P. Abraham, S. Panda, B. Bhargava
This study compares the pathogenicity of SARS-CoV-2 variants B.1 and B.1.617.1 in hamsters, finding B.1.617.1 causes greater body weight loss, higher viral load, and more severe lung lesions.
bioRxiv · May 5, 2021 · PreprintMicrobiology
P. Yadav, G. N. Sapkal, P. Abraham, R. Ella, G. Deshpande, D. Y. Patil, D. Nyayanit, N. Gupta, R. R. Sahay, A. M. Shete, S. Panda, B. Bhargava, V. K. Mohan
The paper assesses the neutralizing ability of sera from BBV152 vaccinees and convalescent COVID-19 patients against B.1.617 variants.
bioRxiv · Apr 23, 2021Immunology